Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Integrated Tissue Transcriptomic Profiling Reveals Immune and microRNA Dysregulation in Gastrointestinal Acute Graft-Versus-Host Disease

CT - 543

Integrated Tissue Transcriptomic Profiling Reveals Immune and microRNA Dysregulation in Gastrointestinal Acute Graft-Versus-Host Disease

Rachel Crossland

Poster Presenter: Rachel Crossland

Thumbnail for Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

CT - 544

Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

Mahmood Aldapt

Poster Presenter: Mahmood Aldapt

Previous 1...39 40 41 42 43 44 45...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

$Thumbnail for The selective PI3Kδ inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from na?ve and JAK inhibitor-refractory/resistant patients with myelofibrosis$

MPN - 545

The selective PI3Kδ inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from na?ve and JAK inhibitor-refractory/resistant patients with myelofibrosis

Giusy Di Conza

Poster Presenter: Giusy Di Conza

Thumbnail for Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor-Treated Patients with Hematologic Malignancies: A Real-World Propensity-Matched Analysis

CML - 547

Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor-Treated Patients with Hematologic Malignancies: A Real-World Propensity-Matched Analysis

Antonio Arciniegas

Poster Presenter: Antonio Arciniegas

Thumbnail for Navigating Bispecifics Outpatient Step-Up Dosing: A Roadmap to Help Improve Safety and Access in the Real-World (NORTHSTAR)

MM - 548

Navigating Bispecifics Outpatient Step-Up Dosing: A Roadmap to Help Improve Safety and Access in the Real-World (NORTHSTAR)

Muhamed Baljevic

Poster Presenter: Muhamed Baljevic

Thumbnail for Two-Year Rituximab Maintenance vs Observation After First-Line Treatment With Bendamustine Plus Rituximab (B-R) in Patients With Waldenström’s Macroglobulinemia: Results of a Prospective, Randomized Multicenter Phase 3 Study (StiL NHL7-2008 MAINTAIN Trial

IBCL - 549

Two-Year Rituximab Maintenance vs Observation After First-Line Treatment With Bendamustine Plus Rituximab (B-R) in Patients With Waldenström’s Macroglobulinemia: Results of a Prospective, Randomized Multicenter Phase 3 Study (StiL NHL7-2008 MAINTAIN Trial

Mathias Rummel

Poster Presenter: Mathias Rummel

Thumbnail for Plasma Cytokeratin 18 (Ck-18) Fragment in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia

AML - 550

Plasma Cytokeratin 18 (Ck-18) Fragment in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia

aliaa nabil

Poster Presenter: aliaa nabil

Thumbnail for Real-World Insights Into Demographic Profiles and Barriers to Hematopoietic Stem Cell Transplantation in Pakistan: A Single-Center Experience

AML - 551

Real-World Insights Into Demographic Profiles and Barriers to Hematopoietic Stem Cell Transplantation in Pakistan: A Single-Center Experience

Maleeha Akbar

Poster Presenter: Maleeha Akbar

Thumbnail for Administering Tafasitamab, Lenalidomide and Rituximab for Follicular Lymphoma: a Single Institution Experience From the Phase 3 inMIND Study

IBCL - 552

Administering Tafasitamab, Lenalidomide and Rituximab for Follicular Lymphoma: a Single Institution Experience From the Phase 3 inMIND Study

Danielle Janiszewski

Poster Presenter: Danielle Janiszewski

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors